Axsome Therapeutics (AXSM) Reports Sunosi Met Primary Endpoi

Axsome Therapeutics (AXSM) Reports Sunosi Met Primary Endpoint in SHARP Trial

Axsome Therapeutics (AXSM) Reports Sunosi Met Primary Endpoint in SHARP Trial
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

China , Japan , United States , United Kingdom , British , Richard Bogan , Herriot Tabuteau , Sk Biopharmaceuticals Co Ltd , Psych Congress , Axsome Therapeutics Inc , Drug Administration , Continuous Positive Airway Pressure , Health Qual Life Outcomes , Nasdaq , Us Drug Enforcement Agency On , Airway Pressure , University Of South Carolina School Medicine , Psych Congress On , Wall Street , Digit Symbol Substitution Test , Repeatable Battery , Neuropsychological Status , Cognitive Health , Apnea Participants During , Randomized Placebo Controlled Study , British Columbia Cognitive Complaints Inventory , Epworth Sleepiness Scale , Associate Clinical Professor , South Carolina School , Medical University , South Carolina , Bogan Sleep , Chief Executive Officer , Data Demonstrating Activation , Solriamfetol Presented , Digit Symbol Substitution , Patient Global Impression , Enforcement Agency , Full Prescribing Information , Medication Guide , Prescribing Information , Obstructive Sleep Apnea , Excessive Daytime Sleepiness , Associated Cognitive , Axsome Therapeutics , Floornew York , Potential Mechanisms , Psych Congress September , Equal Life ,